SINUS QUICK IT SYSTEM

K090527 · Neobiotech Co., Ltd. · DZE · Jul 14, 2009 · Dental

Device Facts

• Record ID: K090527
• Device Name: SINUS QUICK IT SYSTEM
• Applicant: Neobiotech Co., Ltd.
• Product Code: DZE · Dental
• Decision Date: Jul 14, 2009
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 872.3640
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The SQ IT System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, screw retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. IT System is dedicated for two stage surgical procedures and for immediate loading.

Device Story

SQ IT System is an endosseous dental implant system; surgically placed in upper or lower jaw bone to support dental restorations. Device consists of titanium metal implants; surface treated with R.B.M. (Resorbable Blast Media). Used by dental clinicians in clinical settings for patients requiring tooth replacement. System supports single/multiple-unit restorations, including cemented, screw-retained, or overdenture configurations; serves as terminal or intermediate abutment for fixed bridgework. Supports two-stage surgical protocols and immediate loading. Benefits include restoration of oral function and aesthetics for edentulous patients.

Clinical Evidence

Bench testing only. Mechanical testing was performed in accordance with the FDA guidance document 'Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments' (May 12, 2004). Results demonstrated that the SQ IT System possesses mechanical strength at least equivalent to the predicate device.

Technological Characteristics

Material: TI6Al-4V ELI (ASTM and ISO standards). Surface treatment: R.B.M. (Resorbable Blast Media). Form factor: Endosseous root-form dental implant. Energy source: N/A (mechanical). Connectivity: N/A. Sterilization: Not specified.

Indications for Use

Indicated for patients with partially or fully edentulous mandibles and maxillae requiring single or multiple-unit restorations, including cemented, screw-retained, or overdenture restorations, and fixed bridgework support. Suitable for two-stage surgical procedures and immediate loading.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Predicate Devices

• SS System (K062051)

Submission Summary (Full Text)

{0}------------------------------------------------

K090527

. of z

JL 1 4 2009

## 510(K) Summary

### Submitter

Neobiotech Co., Ltd. Heo Young Goo E-Space #103, 104, 105, 205. Guro-dong, Guro-gu Seoul, 152-050, South Korea Tel: [phone] Fax: [phone]

US Agent / Official Contact Kodent Inc. Jung Bae Bang 13340 East Firestone Blvd. Suite J Santa Fe Springs, CA 90670 Tel: [phone] Fax: [phone] Email: [e-mail]

### Device Information

Product Name: SQ IT System

Common Name: Endosseous Dental Implant

Classification Name: Implant, Endosseous, Root-Form

Product Code: DZE

Regulation Number: 872.3640

Device Class: Class II

### Device Description

The SQ IT System is a dental implant system made of titanium metal intended to be surgically placed in the bone of the upper or lower jaw arches. The system is similar to other commercially available products based on the intended use, the technology used, the claims, the material composition employed and performance characteristics. IT System is made from pure titanium and the surface treatment is done with R,B.M.

#### Indication for Use

The SQ IT System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. IT System is dedicated for two stage surgical procedures and for immediate loading.

{1}------------------------------------------------

K090527

#### Materials:

This device is manufactured from TI6Al-4V ELI following the ASTM and ISO standards.

### Predicate Devices:

The subject device is substantially equivalent to the following predicate devices:

- SS System (Osstem Co., Ltd .; K062051) .
# Comparison to Predicate Devices:

Testing and other comparisons have established that the subject of SQ IT System is substantially equivalent in design, materials, indications and intended use, packaging, labeling, and performance to other predicate devices of the type currently marketed in the U.S.

### Performance Data:

All of the data consistent with the recommendations in the FDA guidance document Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments, May 12, 2004, mechanical testing of the implants demonstrated that the SQ IT System possess mechanical strength at least equivalent to the predicate devices.

{2}------------------------------------------------

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES . USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird-like figure with three stylized wing segments.

JUL 1 4 2009

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Neobiotech Company, Limited C/O Mr. Jung Bae Bang Kodent Incorporated 13340 East Firestone Boulevard, Suite J Santa Fe Springs, California 90670

Re: K090527

Trade/Device Name: SQ IT System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE Dated: July 8, 2009 Received: July 8, 2009

Dear Mr. Bang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

## Page 2 – Mr. Bang

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/ CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807,97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Susan Dunne

Susan Runner, D.D.S., M.A. Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

### Enclosure

{4}------------------------------------------------

K090527

1 of 1

Indication for Use

510(K) Number (if known):

Device Name: SQ IT System

## Indication for Use:

The SQ IT System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, screw retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. IT System is dedicated for two stage surgical procedures and for immediate loading.

Prescription Use

AND/OR

Over-The-Counter

(Per 21 CFR 801 Subpart C)

(Part 21 CFR 801 Subpart D)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Kim Muly for MSR
(Division Sign-Off)

Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Number: K090527

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of 1